Mogelijk gemaakt door Google TranslateTranslate
Latest Press Releases
View all
TimeHeadline
11m agoFatPipe Unveils VeloCloud Replacement Program with Price Match, 15% Discounts and 10% Partner Rebates
37m agoAngle Advisors announces Shift Transit has been recapitalized by Main Street Capital Corporation
37m agoCentury Complete Announces New Homes Coming Soon to Fleming Island, FL
37m agoSprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
38m agoTambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning

Collegium Pharmaceutical Inc

About

Collegium Pharmaceutical Inc (NASDAQ:COLL) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 23 2026
Collegium to Report First Quarter 2026 Financial Results on May 7, 2026
Mar 19 2026
Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory
Mar 5 2026
Collegium to Present New Real-World Data at PainConnect 2026
Mar 3 2026
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community
Feb 26 2026
Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results

Financials

Revenue
$780.57 M
Market Cap
$1.03 B
P/E Ratio
18.68
EPS
1.73

Community Chat

Ask AI

6ix6ixAIEvents
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren